About Perry Nisen
Perry Nisen is a chief executive officer and director at Quanta Therapeutics.
Perry Nisen first appears on SEC filings in 2021.
Experience
This experience comes from Perry Nisen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Perry Nisen in the role, so the role may have started earlier or lasted longer.
Quanta Therapeutics, Inc. Current
Chief Executive Officer and director
2021 – Present · South San Francisco, CA
Develops cancer medicines for patients with RAS-driven cancers.
SI
Sofinnova Investments Current
Executive Partner/Advisor
2018 – Present
TP
Teva Pharmaceuticals Current
Independent Director, Chair of Science and Technology
2017 – Present
SI
Sanford Burnham Prebys Medical Discovery Institute
Chief Executive Officer, Donald Bren Chief Executive Chair
2014 – 2017
GL
GlaxoSmithKline
SVP Science and Innovation
2010 – 2014
GS
GSK
SVP Cancer Research
2004 – 2010
AB
Abbott
Division VP Global Oncology Development
1997 – 2004
UC
UT Southwestern Medical Center
Professor
1989 – 1997
Key Colleagues at Startups
The people Perry Nisen works with at each company, as listed on that company's latest Form D.
Quanta Therapeutics, Inc. · Form D/A, Jun 24, 2026
MK
Maha Katabi
Director
CP
Cameron Pitt
Chief Operating Officer and director
MF
Maria Fardis
Director
YH
Ying Huang
Director
DM
Derek Metzger
Chief Strategy Officer
RJ
Rajul Jain
Director